TC
MRNA icon

Truvestments Capital’s Moderna MRNA Stock Holding History

Truvestments Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-255
Closed -$6.59K – 1081
2025
Q3 		$6.59K Buy
+255
New +$7.11K ﹤0.01% 772
2025
Q1 		– Sell
-50
Closed -$2.08K – 1111
2024
Q4 		$2.08K Buy
+50
New +$2.39K ﹤0.01% 841
2024
Q1 		– Sell
-200
Closed -$19.9K – 817
2023
Q4 		$19.9K Buy
+200
New +$16.8K 0.01% 439

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Truvestments Capital's MRNA Position: Q4 2025 in Review

Truvestments Capital sold out of Moderna (MRNA) in Q4 2025, closing a stake of 255 shares — an estimated $6.59K sold.

Truvestments Capital first reported a position in MRNA in Q4 2023 and held it in 3 quarters. The position peaked at $19.9K in Q4 2023. 675 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Truvestments Capital reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Truvestments Capital sold 255 Moderna shares in Q4 2025, an estimated $6.59K.
  • Truvestments Capital first reported a position in Moderna in Q4 2023 and held it in 3 quarters.
  • Truvestments Capital's Moderna position peaked at $19.9K in Q4 2023.
  • 675 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Truvestments Capital's 13F filing for Q4 2025, filed 13 Feb 2026.